Weill Medical College Of Cornell University
Clinical trials sponsored by Weill Medical College Of Cornell University, explained in plain language.
-
Cancer drug cabozantinib tested in Tough-to-Treat prostate cancer
Disease control TerminatedThis phase 2 trial tested the drug cabozantinib in men with a type of advanced prostate cancer that no longer responds to hormone therapy. The study focused on patients whose tumors had specific genetic changes or had spread to the liver. Only 4 men were enrolled before the trial…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Experimental combo for tough lymphoma shows early promise, but trial halted
Disease control TerminatedThis early-stage trial tested a combination of two oral drugs, tazemetostat and venetoclax, in people with non-Hodgkin lymphoma that had come back or stopped responding to treatment. Only 3 people enrolled before the study was terminated. The main goals were to find the safest do…
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
Experimental brain tumor treatment tested in just one patient
Disease control TerminatedThis early-stage trial tested giving chemotherapy directly into the arteries of the brain for people with rare choroid plexus tumors. The goal was to shrink the tumor before a second surgery. Only one person enrolled, and the study was stopped early, so we don't know if this appr…
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
New antibiotic strategy targets deadly infections in vulnerable patients
Disease control TerminatedThis study tested whether the antibiotic ceftolozane-tazobactam can effectively treat serious Pseudomonas aeruginosa infections in people with blood cancers or those who had a stem cell transplant. Participants received the drug through a vein every 8 hours for 10 to 14 days. Res…
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
Nail psoriasis injection study halted after just one person
Symptom relief TerminatedThis study tested whether injecting methotrexate directly into the nail area could improve nail psoriasis symptoms like pitting and discoloration. Only one person enrolled before the trial was stopped early. The goal was to measure changes in nail appearance using a severity scor…
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 22, 2026 12:06 UTC
-
Fewer radiation sessions may mean fewer side effects for prostate cancer patients
Symptom relief TerminatedThis study looked at men with low or intermediate-risk prostate cancer to see if 2 MRI-guided radiation treatments cause fewer bowel and bladder side effects than 5 treatments. The goal was to find a shorter treatment plan that is just as safe and less bothersome. The study was s…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 17, 2026 12:08 UTC